Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins

被引:99
作者
Huang, Tsai-Ying [2 ]
Hsu, Lee-Ping [1 ,3 ]
Wen, Yu-Hsuan [1 ]
Huang, Tung-Tsun [1 ,3 ]
Chou, Yu-Fu [1 ]
Lee, Chia-Fong [1 ,3 ]
Yang, Miao-Chun [1 ]
Chang, Yi-Kuo [1 ]
Chen, Peir-Rong [1 ,3 ]
机构
[1] Buddhist Tzu Chi Gen Hosp, Dept Otolaryngol, Hualien, Taiwan
[2] Buddhist Tzu Chi Gen Hosp, Dept Radiat Oncol, Hualien, Taiwan
[3] Tzu Chi Univ, Dept Med, Hualien, Taiwan
关键词
Oral cavity cancer; Early stage; Recurrence; Survival; Predictor; SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASIS; TUMOR THICKNESS; PROGNOSTIC-FACTORS; TONGUE; NECK; CHEMOTHERAPY; SURVIVAL; INVASION; HEAD;
D O I
10.1016/j.oraloncology.2009.10.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Locoregional recurrence in patients with early stage oral cavity squamous cell carcinoma (ESOSCC) after surgery remains a problem and can affect their survival. We sought to identify new high-risk factors in these patients, who need further adjuvant therapy. We retrospectively reviewed records for 148 patients who underwent surgery for ESOSCC between 2002 and 2006 with negative surgical margins. The primary endpoint was locoregional recurrence. Recurrence-free survival (RFS) and overall survival (OS) were calculated by the Kaplan-Meier method. Univariate and multivariate analyses were used to identify independent predictors of locoregional recurrence. All patients were grouped into the low-and high-risk groups according to the odds ratios (OR) of the predictors. Recurrence rates of the low-and high-risk groups were then predicted. Recurrence was observed in 17 of 148 (11.5%) patients at the end of this study. None of the patients received postoperative radiotherapy or chemotherapy. At 3 years, the RFS rate was 89.7% and the OS rate at 3 years was 84.1%. Univariate analysis of the RFS revealed three significant prognostic factors: lymphovascular permeation (LVP, p < 0.001), perineural infiltration (PNI, p = 0.08), and non-T4 muscular invasion (non-T4MI, p < 0.005). Multivariate analysis demonstrated that LVP (p = 0.007, OR = 10.7) and non-T4 MI (p = 0.001, OR = 8.347) were independent predictors. The recurrence rate was 1.96% in patients without LVP or non-T4MI, and it increased to 26.47% in patients with non-T4MI, to 50% in patients with LVP, and to 50% in patients with both. According to the status of LVP and non-T4MI, patients were divided into two groups: low-risk (no factors present) and high-risk (one or both factors present) groups. The 2-year RFS was lower in the high-risk group (84.13%) than in the low-risk group (93.91%); the 3-year RFS was also lower in the high-risk group (70.49%) than in the low-risk group (91.99%) (p = 0.008). Subgroup analysis revealed that elective neck dissections did not affect the outcome or change the pattern of failure. For patients with elective neck dissections, the RFS was lower in the high-risk group than in the low-risk group (p = 0.03). In ESOSCC (pT1-2N0), LVP and non-T4MI significantly increased the recurrence rate. The presence of one or both factors (LVP and/or non-T4MI) should be considered as a high-risk condition for locoregional recurrence, and adjuvant therapy is needed in such cases. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 16 条
[1]
Early stage carcinoma of oral tongue: prognostic factors for local control and survival [J].
Al-Rajhi, N ;
Khafaga, Y ;
El-Husseiny, J ;
Saleem, M ;
Mourad, W ;
Al-Otieschan, A ;
Al-Amro, A .
ORAL ONCOLOGY, 2000, 36 (06) :508-514
[2]
ANTHONY S, 2004, OTOLARYNGOL HEAD NEC, V131, P472
[3]
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer [J].
Bernier, J ;
Domenge, C ;
Ozsahin, M ;
Matuszewska, K ;
Lefèbvre, JL ;
Greiner, RH ;
Giralt, J ;
Maingon, P ;
Rolland, F ;
Bolla, M ;
Cognetti, F ;
Bourhis, J ;
Kirkpatrick, A ;
van Glabbeke, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1945-1952
[4]
Byers RM, 1998, HEAD NECK-J SCI SPEC, V20, P138, DOI 10.1002/(SICI)1097-0347(199803)20:2<138::AID-HED7>3.0.CO
[5]
2-3
[6]
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck [J].
Cooper, JS ;
Pajak, TF ;
Forastiere, AA ;
Jacobs, J ;
Campbell, BH ;
Saxman, SB ;
Kish, JA ;
Kim, HE ;
Cmelak, AJ ;
Rotman, M ;
Machtay, M ;
Ensley, JF ;
Chao, KSC ;
Schultz, CJ ;
Lee, N ;
Fu, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1937-1944
[7]
ELECTIVE VERSUS THERAPEUTIC NECK DISSECTION IN EARLY CARCINOMA OF THE ORAL TONGUE [J].
FAKIH, AR ;
RAO, RS ;
BORGES, AM ;
PATEL, AR .
AMERICAN JOURNAL OF SURGERY, 1989, 158 (04) :309-313
[8]
Fukano H, 1997, HEAD NECK-J SCI SPEC, V19, P205, DOI 10.1002/(SICI)1097-0347(199705)19:3<205::AID-HED7>3.0.CO
[9]
2-6
[10]
Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue [J].
Kurokawa, H ;
Yamashita, Y ;
Takeda, S ;
Zhang, M ;
Fukuyama, H ;
Takahashi, T .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (08) :731-736